BNP Paribas Financial Markets’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Buy |
215,414
+209,227
| +3,382% | +$1.5M | ﹤0.01% | 1987 |
|
|
2025
Q1 | $37.1K | Sell |
6,187
-60,597
| -91% | -$363K | ﹤0.01% | 3546 |
|
|
2024
Q4 | $521K | Buy |
+66,784
| New | +$521K | ﹤0.01% | 2473 |
|
|
2022
Q4 | – | Sell |
-175,767
| Closed | -$2.62M | – | 3484 |
|
|
2022
Q3 | $2.62M | Buy |
+175,767
| New | +$2.62M | ﹤0.01% | 1263 |
|
|
2020
Q3 | – | Sell |
-10
| Closed | -$17 | – | 3586 |
|
|
2020
Q2 | $17 | Sell |
10
-25
| -71% | -$43 | ﹤0.01% | 3623 |
|
|
2020
Q1 | $58 | Hold |
35
| – | – | ﹤0.01% | 3617 |
|
|
2019
Q4 | $101 | Sell |
35
-530
| -94% | -$1.53K | ﹤0.01% | 3660 |
|
|
2019
Q3 | $3.25K | Hold |
565
| – | – | ﹤0.01% | 3674 |
|
|
2019
Q2 | $5.92K | Sell |
565
-508
| -47% | -$5.32K | ﹤0.01% | 3589 |
|
|
2019
Q1 | $18.8K | Buy |
1,073
+1,057
| +6,606% | +$18.6K | ﹤0.01% | 3326 |
|
|
2018
Q4 | $277 | Sell |
16
-13
| -45% | -$225 | ﹤0.01% | 3380 |
|
|
2018
Q3 | $1.2K | Hold |
29
| – | – | ﹤0.01% | 3637 |
|
|
2018
Q2 | $1.67K | Buy |
+29
| New | +$1.67K | ﹤0.01% | 3621 |
|